Healthy Extracts Inc Financials

HYEX

Trailing 12 months to June 30, 2026

Revenue $6.3M +84.1% YoY

Net Income -$879K -107.1% YoY

Operating Cash Flow $500K +191.9% YoY

Gross Profit $3.8M +89.0% YoY

Market Cap $17.2M as of Aug 25, 2026

Price / Sales 2.7x on $6.3M revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 0.8x on $22.4M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Aug 25, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 14, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HYEX SEC filings page.

Healthy Extracts Inc (HYEX) reported $6.3M in revenue over the twelve months to Jun 30, 2026, up 84.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HYEX FY2025 2026-08-30

The dominant mechanic is growth with margin compression, while reported balance-sheet strength is concentrated in goodwill rather than operating scale.

Revenue expanded from FY2023 to FY2025 while gross margin compressed from 65.2% to 53.7%, indicating that added volume came with weaker unit economics rather than clean operating leverage. FY2025 operating cash flow was positive despite a net loss, yet lower than FY2024, so cash conversion does not confirm recurring earnings.

Total assets rose from $2.4M in FY2024 to $27.8M in FY2025, marking a major balance-sheet shift unrelated to the pace of revenue growth. Goodwill increased from $193K to $21.1M, meaning reported equity rests heavily on an intangible asset rather than accumulated operating resources.

FY2025's current ratio was 0.8x, with current liabilities exceeding current assets, even though debt-to-equity was only 0.2x; the business is not principally debt-funded, but near-term obligations remain comparatively tight. SG&A exceeded gross profit in FY2025, leaving the gross-profit pool insufficient to absorb operating overhead before interest.

Financial Health Signals

Financial health score not available

Healthy Extracts Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

3/8

Healthy Extracts Inc passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Mixed

N/A

Healthy Extracts Inc reported a net loss of $881K while generating $166K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.1M

YoY+113.4%

QoQ+28.3%

5Y CAGR+53.3%

Healthy Extracts Inc generated $2.1M in revenue in Q2 2026. This represents an increase of 113.4% from the same quarter a year earlier. Against the prior quarter it is up 28.3%.

Net Income

-$129K

YoY-292.8%

QoQ+35.5%

Healthy Extracts Inc reported -$129K in net income in Q2 2026. This represents a decrease of 292.8% from the same quarter a year earlier. Against the prior quarter it is up 35.5%.

EBITDA

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$190K

YoY-5.3%

QoQ+15.6%

5Y CAGR-7.9%

10Y CAGR+22.0%

Healthy Extracts Inc held $190K in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

15M

YoY-12.6%

QoQ-12.7%

5Y CAGR-45.9%

Healthy Extracts Inc had 15M shares outstanding in Q2 2026. This represents a decrease of 12.6% from the same quarter a year earlier. Against the prior quarter it is down 12.7%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

70.3%

YoY+9.1pp

QoQ+8.9pp

5Y CAGR-15.9pp

Healthy Extracts Inc's gross margin was 70.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 9.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 8.9 percentage points.

Net Margin

-6.3%

YoY-13.2pp

QoQ+6.2pp

Healthy Extracts Inc's net profit margin was -6.3% in Q2 2026, showing the share of revenue converted to profit. This is down 13.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.2 percentage points.

Return on Equity

-0.6%

YoY-14.6pp

QoQ+0.3pp

Healthy Extracts Inc's ROE was -0.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 14.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

None of these metrics is reported for Q2 2026.

HYEX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HYEX quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Revenue	$6.3M	$4.5M+44.9%	$3.1M+25.2%	$2.5M+10.4%	$2.3M+34.3%	$1.7M+29.0%	$1.3M+73.6%	$748K+1014.8%	$67K+782.7%	$8K-95.3%	$163K+40.8%	$116K
Cost of Revenue	$2.4M	$2.1M+73.8%	$1.2M+39.1%	$864K-1.8%	$880K+58.0%	$557K+19.8%	$465K+367.2%	$100K+248.1%	$29K+500.5%	$5K-82.3%	$27K-42.2%	$47K
Gross Profit	$3.8M	$2.4M+26.7%	$1.9M+17.9%	$1.6M+18.2%	$1.4M+97.3%	$695K-16.7%	$834K+272.7%	$224K+480.9%	$39K+1255.2%	$3K-97.9%	$136K+97.1%	$69K
SG&A Expenses	$5.0M	$3.4M+60.7%	$2.1M-45.8%	$3.9M+69.3%	$2.3M-11.7%	$2.6M+75.2%	$1.5M+26.7%	$1.2M+279.1%	$307K-43.0%	$539K-29.0%	$758K+96.2%	$387K
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$3.6M	N/A	-$731K
EBITDA	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$3.6M	N/A	-$729K
Interest Expense	-$237K	-$210K-12.9%	-$186K-5.3%	-$177K-173.5%	-$65K-23.3%	-$52K+28.0%	-$73K+16.7%	-$87K	N/A	-$2.6M	N/A	$61
Income Tax	N/A	$0	$0	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$879K	-$881K-4.8%	-$841K+66.0%	-$2.5M-151.5%	-$983K+50.5%	-$2.0M+22.9%	-$2.6M-507.2%	$633K	N/A	-$3.6M	N/A	-$731K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$2.1M+113.4%	$1.6M+73.0%	$1.7M+119.7%	$918K+23.2%	$969K+6.6%	$931K+35.2%	$771K+15.3%	$745K+21.4%
Cost of Revenue	$615K+63.6%	$622K+22.9%	$737K+106.5%	$471K+230.4%	$376K-11.0%	$506K+80.5%	$357K+245.6%	$142K+18.4%
Gross Profit	$1.5M+145.0%	$989K+132.6%	$957K+131.0%	$447K-25.8%	$593K+22.0%	$425K+4.1%	$414K-26.7%	$602K+22.1%
SG&A Expenses	$1.5M+114.9%	$1.3M+146.8%	$1.2M+101.4%	$907K+75.5%	$698K+40.2%	$534K+13.5%	$609K-31.4%	$517K-31.4%
Interest Expense	-$107K-264.4%	$85K+145.7%	-$159K-189.9%	-$56K-40.6%	-$29K+40.0%	$35K+181.2%	-$55K-44.0%	-$40K-63.1%
Income Tax	N/A	$0	N/A	N/A	N/A	$0	N/A	N/A
Net Income	-$129K-292.8%	-$201K+49.7%	-$154K+65.6%	-$395K-211.5%	$67K-40.9%	-$399K+53.7%	-$447K-18.2%	$354K+243.0%

Not reported in any period shown, so not listed: R&D Expenses, Operating Income, EBITDA, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

HYEX Balance Sheet

HYEX quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Total Assets	$27.8M+1070.1%	$2.4M-9.8%	$2.6M-5.3%	$2.8M-8.2%	$3.0M-2.8%	$3.1M-9.7%	$3.4M+3921.9%	$86K-92.4%	$1.1M+668.0%	$146K-5.8%	$155K
Current Assets	$1.3M-20.0%	$1.7M-12.6%	$1.9M-7.0%	$2.0M-11.7%	$2.3M-7.1%	$2.5M-23.2%	$3.2M+56296.1%	$6K-96.1%	$148K+2.7%	$144K-4.3%	$150K
Cash & Equivalents	$147K+31.2%	$112K+476.2%	$19K-70.4%	$66K-70.4%	$222K+275.2%	$59K-55.6%	$133K+27415.7%	$485-99.4%	$82K+238.8%	$24K+1469.1%	$2K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$843K-38.0%	$1.4M-16.3%	$1.6M-10.6%	$1.8M-7.1%	$2.0M-19.0%	$2.4M-21.5%	$3.1M+616131.6%	$500-99.0%	$48K	N/A	N/A
Accounts Receivable	$188K+1606.4%	$11K-63.9%	$30K-71.2%	$106K-20.7%	$133K+904.5%	$13K-49.9%	$26K	N/A	$16K-75.8%	$66K+50.0%	$44K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$21.1M+10830.3%	$193K0.0%	$193K0.0%	$193K0.0%	$193K0.0%	$193K0.0%	$193K	N/A	$842K	N/A	N/A
Total Liabilities	$3.8M+92.9%	$2.0M+17.1%	$1.7M+84.7%	$910K+62.8%	$559K+113.6%	$262K-93.9%	$4.3M+18.2%	$3.6M+58.6%	$2.3M-8.1%	$2.5M+9861.8%	$25K
Current Liabilities	$1.8M+31.6%	$1.3M-20.3%	$1.7M+86.1%	$903K+61.5%	$559K+113.6%	$262K-93.9%	$4.3M+18.2%	$3.6M+58.6%	$2.3M-8.1%	$2.5M+9861.8%	$25K
Non-Current Liabilities	$2.0M+223.6%	$628K	$0-100.0%	$7K	$0	$0	$0	$0	$0	$0	$0
Total Equity	$24.0M+15745.8%	$152K-84.1%	$955K-49.0%	$1.9M-24.3%	$2.5M-13.4%	$2.9M+429.7%	-$866K+75.7%	-$3.6M-202.3%	-$1.2M+50.0%	-$2.4M-1915.3%	$130K
Retained Earnings	-$20.1M-4.6%	-$19.2M-4.6%	-$18.4M-15.5%	-$15.9M-6.6%	-$14.9M-15.3%	-$13.0M-24.8%	-$10.4M+5.7%	-$11.0M-43.3%	-$7.7M-86.4%	-$4.1M-449.2%	-$750K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$32.6M+1206.7%	$27.3M+1032.9%	$27.8M+1070.1%	$26.2M+961.3%	$2.5M+0.4%	$2.4M-7.4%	$2.4M-9.8%	$2.5M-6.5%
Current Assets	$1.7M+7.6%	$1.1M-26.5%	$1.3M-20.0%	$1.7M-0.2%	$1.6M-10.8%	$1.5M-20.8%	$1.7M-12.6%	$1.7M-9.1%
Cash & Equivalents	$190K-5.3%	$164K+38.4%	$147K+31.2%	$189K+88.7%	$200K+35.3%	$119K+36.1%	$112K+476.2%	$100K+116.4%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$644K-41.8%	$521K-54.4%	$843K-38.0%	$967K-32.8%	$1.1M-16.1%	$1.1M-26.4%	$1.4M-16.3%	$1.4M-5.9%
Accounts Receivable	$607K+15151.7%	$254K+262.5%	$188K+1606.4%	$31K+58.2%	$4K-95.6%	$70K+190.9%	$11K-63.9%	$20K-81.9%
Long-Term Investments	$0	$0	$0	$23.5M	$0	$0	$0	$0
Goodwill	$26.1M+13382.6%	$21.1M+10830.3%	$21.1M+10830.3%	$193K0.0%	$193K0.0%	$193K0.0%	$193K0.0%	$193K0.0%
Total Liabilities	$10.2M+404.2%	$3.3M+42.0%	$3.8M+92.9%	$2.1M+27.9%	$2.0M-3.2%	$2.4M-4.2%	$2.0M+17.1%	$1.7M+3.0%
Current Liabilities	$8.4M+873.4%	$1.6M-32.6%	$1.8M+31.6%	$1.2M-29.5%	$862K-58.7%	$2.4M-4.2%	$1.3M-20.3%	$1.7M+3.0%
Non-Current Liabilities	$1.8M+54.4%	$1.8M	$2.0M+223.6%	$956K	$1.2M	$0+100.0%	$628K	$0
Total Equity	$22.4M+4594.1%	$24.0M+39533.8%	$24.0M+15745.8%	$24.1M+2896.6%	$478K+19.5%	$61K-60.1%	$152K-84.1%	$803K-21.6%
Retained Earnings	-$20.5M-4.5%	-$20.3M-3.5%	-$20.1M-4.6%	-$20.0M-6.2%	-$19.6M-2.2%	-$19.6M-2.0%	-$19.2M-4.6%	-$18.8M-4.3%

Not reported in any period shown, so not listed: Long-Term Debt.

HYEX Cash Flow Statement

HYEX quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Operating Cash Flow	$500K	$166K-41.3%	$282K+167.8%	-$416K-6.4%	-$391K+56.7%	-$901K+52.6%	-$1.9M-9.9%	-$1.7M-426.5%	-$329K+51.1%	-$672K-25.2%	-$537K-7.9%	-$498K
Depreciation & Amortization	N/A	N/A	N/A	N/A	N/A	$5K-43.6%	$9K+6.1%	$9K+2.3%	$8K+169.3%	$3K+132.8%	$1K-16.3%	$2K
Stock-Based Compensation	N/A	N/A	N/A	N/A	$0	$0	N/A	$111K	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	$0-100.0%	$8K	$0	N/A	$23K	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	-$416K-4.3%	-$399K+55.8%	-$901K	N/A	-$1.8M	N/A	N/A	N/A	N/A
Investing Cash Flow	$172K	$56K	$0	$0+100.0%	-$5K+94.4%	-$96K+17.1%	-$116K-305.5%	$56K+12.6%	$50K+219.1%	-$42K+12.3%	-$48K-654.0%	-$6K
Financing Cash Flow	-$682K	-$187K+1.3%	-$189K-151.3%	$370K+54.3%	$240K-79.4%	$1.2M-40.3%	$1.9M+7.6%	$1.8M+814.8%	$198K-74.4%	$772K+27.0%	$608K+20.3%	$505K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$306K+1677.6%	$106K+76.6%	$368K+779.1%	-$280K-635.3%	$17K-89.8%	$60K+220.6%	$42K-24.7%	$52K+177.0%
Investing Cash Flow	$96K+597.2%	$0	$76K	$0	-$19K	$0	$0	$0
Financing Cash Flow	-$376K-549.3%	-$89K-66.3%	-$486K-1507.0%	$269K+368.5%	$84K+177.5%	-$53K-208.3%	-$30K+63.4%	-$100K-559.8%

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

HYEX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HYEX quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Gross Margin	53.7%-7.7pp	61.4%-3.8pp	65.2%+4.3pp	60.9%+19.5pp	41.5%-22.8pp	64.2%+34.3pp	29.9%-27.5pp	57.4%+20.0pp	37.4%-46.1pp	83.5%+23.8pp	59.7%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-47911.7%	N/A	-632.6%
Net Margin	-19.5%+7.5pp	-27.0%+72.5pp	-99.5%-55.8pp	-43.7%	-118.5%	-198.3%	84.5%	N/A	-46838.6%	N/A	-632.5%
Return on Equity	-3.7%+550.7pp	-554.4%-295.3pp	-259.1%-206.5pp	-52.5%+27.9pp	-80.4%+9.9pp	-90.3%	N/A	N/A	N/A	N/A	-562.3%
Return on Assets	-3.2%+32.2pp	-35.4%+58.5pp	-93.8%-58.5pp	-35.4%+30.2pp	-65.6%+17.1pp	-82.7%-101.0pp	18.3%	N/A	-317.3%	N/A	-471.2%
Current Ratio	0.75-0.5x	1.24+0.1x	1.13-1.1x	2.26-1.9x	4.14-5.4x	9.52+8.8x	0.75+0.7x	0.00-0.1x	0.060.0x	0.06-5.9x	5.98
Debt-to-Equity	0.16-12.8x	12.97+11.2x	1.76+1.3x	0.49+0.3x	0.23+0.1x	0.09	N/A	N/A	N/A	N/A	0.19
Asset Turnover	0.16-1.1x	1.31+0.4x	0.94+0.1x	0.81+0.3x	0.55+0.1x	0.42+0.2x	0.22-0.6x	0.78+0.8x	0.01-1.1x	1.11+0.4x	0.74
FCF Margin	N/A	N/A	-16.7%+1.0pp	-17.7%+36.1pp	-53.8%	N/A	-234.3%	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	70.3%+9.1pp	61.4%+15.8pp	56.5%+2.8pp	48.7%-32.2pp	61.2%+7.7pp	45.6%-13.7pp	53.7%-30.8pp	80.9%+0.5pp
Net Margin	-6.3%-13.2pp	-12.4%+30.4pp	-9.1%+48.9pp	-43.1%-90.7pp	6.9%-5.6pp	-42.8%	-58.0%-1.4pp	47.6%+88.0pp
Return on Equity	-0.6%-14.6pp	-0.8%+658.4pp	-0.6%+294.4pp	-1.6%-45.8pp	14.0%-14.3pp	-659.2%-91.2pp	-295.0%-255.4pp	44.1%+68.3pp
Return on Assets	-0.4%-3.1pp	-0.7%+15.8pp	-0.5%+18.3pp	-1.5%-15.9pp	2.7%-1.9pp	-16.5%+16.5pp	-18.8%-4.4pp	14.4%+23.8pp
Current Ratio	0.20-1.6x	0.69+0.1x	0.75-0.5x	1.47+0.4x	1.81+1.0x	0.63-0.1x	1.24+0.1x	1.04-0.1x
Debt-to-Equity	0.45-3.8x	0.14-38.7x	0.16-12.8x	0.09-2.0x	4.22-1.0x	38.85+22.7x	12.97+11.2x	2.07+0.5x
Asset Turnover	0.06-0.3x	0.06-0.3x	0.06-0.3x	0.04-0.3x	0.390.0x	0.39+0.1x	0.32+0.1x	0.30+0.1x

Not reported in any period shown, so not listed: Operating Margin, FCF Margin.

Note: The current ratio is below 1.0 (0.75), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Healthy Extracts Inc HYEX	FY2025	$4.5M	-$881K	-19.5%	$17.2M	—
Leef Brands LEEEF	FY2025	$34.8M	-$17.6M	-50.7%	$61.4M	—
Eagle Pharmaceut EGRX	FY2022	$316.6M	$35.6M	11.3%	$26.6M	—
C21 Investments CXXIF	FY2026	$32.6M	-$3.2M	-10.0%	$31.4M	—

Where Healthy Extracts Inc Ranks

Frequently Asked Questions

What is Healthy Extracts Inc's annual revenue?

Healthy Extracts Inc (HYEX) reported $4.5M in total revenue for fiscal year 2025. This represents a 44.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Healthy Extracts Inc's revenue growing?

Healthy Extracts Inc (HYEX) revenue grew by 44.9% year-over-year, from $3.1M to $4.5M in fiscal year 2025.

Is Healthy Extracts Inc profitable?

No, Healthy Extracts Inc (HYEX) reported a net income of -$881K in fiscal year 2025, with a net profit margin of -19.5%.

What is Healthy Extracts Inc's gross margin?

Healthy Extracts Inc (HYEX) had a gross margin of 53.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Healthy Extracts Inc's net profit margin?

Healthy Extracts Inc (HYEX) had a net profit margin of -19.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Healthy Extracts Inc's return on equity (ROE)?

Healthy Extracts Inc (HYEX) has a return on equity of -3.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Healthy Extracts Inc's operating cash flow?

Healthy Extracts Inc (HYEX) generated $166K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Healthy Extracts Inc's total assets?

Healthy Extracts Inc (HYEX) had $27.8M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Healthy Extracts Inc have outstanding?

Healthy Extracts Inc (HYEX) had 17M shares outstanding as of fiscal year 2025.

What is Healthy Extracts Inc's current ratio?

Healthy Extracts Inc (HYEX) had a current ratio of 0.75 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Healthy Extracts Inc's debt-to-equity ratio?

Healthy Extracts Inc (HYEX) had a debt-to-equity ratio of 0.16 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Healthy Extracts Inc's return on assets (ROA)?

Healthy Extracts Inc (HYEX) had a return on assets of -3.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Healthy Extracts Inc's P/E ratio?

Healthy Extracts Inc (HYEX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $17.2M as of Aug 25, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Healthy Extracts Inc's price-to-sales ratio?

Healthy Extracts Inc (HYEX) trades at 2.7x sales, its market capitalization divided by revenue of $6.3M revenue, trailing 12 months to June 30, 2026. The market capitalization is $17.2M as of Aug 25, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Healthy Extracts Inc's Piotroski F-Score?

Healthy Extracts Inc (HYEX) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Healthy Extracts Inc's earnings high quality?

Healthy Extracts Inc (HYEX) reported a net loss of $881K while generating $166K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.